
In a controlled test of 12 AI models across 33 physician-written clinical cases, a clearly labeled pharmaceutical ad raised the share of responses choosing the advertised drug from 35% to 47.6%.
Slightly more than half of all U.S. veterans targeted for diabetes screening had unrecognized diabetes or prediabetes, indicating a need for widespread screening in this population.





